Skip to the page

Data / Drug companies / Sicor de Mexico S.A. de C.V

Sicor de Mexico S.A. de C.V: 27 products in the FDA NDC directory, labeler code 63592

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sicor de Mexico S.A. de C.V (labeler code 63592) lists 27 products in the FDA National Drug Code Directory. By type: 27 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 23, 2023.

The request: Watch Sicor de Mexico S.A. de C.V (FDA labeler code 63592): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
63592
Products in commercial distribution
27
Packages
27
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
November 17, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients27100%

Products by type

TypeProductsShare
Bulk ingredients27100%

Dosage forms

Dosage formProductsShare
Powder27100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Olodaterol hcl63592-7600PowderBulk ingredientsFebruary 23, 2023
Gemcitabine hydrochloride63592-4075PowderBulk ingredientsOctober 4, 2021
Ribociclib succinate63592-1600PowderBulk ingredientsSeptember 23, 2020
Fluticasone furoate63592-3370PowderBulk ingredientsJuly 7, 2020
Abiraterone acetate63592-4520PowderBulk ingredientsOctober 18, 2019
Azacitidine63592-1800PowderBulk ingredientsJune 3, 2019
Erlotinib hydrochloride63592-3407PowderBulk ingredientsNovember 5, 2018
Erlotinib hydrochloride63592-3400PowderBulk ingredientsNovember 5, 2018
Mometasone furoate63592-0397PowderBulk ingredientsNovember 5, 2018
Mometasone furoate63592-0387PowderBulk ingredientsNovember 5, 2018
Letrozole63592-3376PowderBulk ingredientsOctober 19, 2018
Prednicarbate63592-2140PowderBulk ingredientsOctober 19, 2018
Oxaliplatin63592-0700PowderBulk ingredientsOctober 19, 2018
Docetaxel anhydrous63592-0360PowderBulk ingredientsOctober 19, 2018
Alclometasone dipropionate63592-0316PowderBulk ingredientsOctober 19, 2018
Carboplatin63592-0271PowderBulk ingredientsOctober 19, 2018
Budesonide63592-0187PowderBulk ingredientsOctober 19, 2018
Amcinonide63592-0177PowderBulk ingredientsOctober 19, 2018
Megestrol acetate63592-0109PowderBulk ingredientsOctober 19, 2018
Medroxyprogesterone acetate63592-0089PowderBulk ingredientsOctober 4, 2018
Lifitegrast63592-3385PowderBulk ingredientsFebruary 5, 2018
Fluticasone propionate micronized63592-0335PowderBulk ingredientsNovember 21, 2017
Aztreonam anhydrous63592-0180PowderBulk ingredientsNovember 21, 2017
Rocuronium bromide63592-0178PowderBulk ingredientsNovember 21, 2017
Nintedanib esylate63592-7200PowderBulk ingredientsJuly 29, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.